Insights from the The Prof G Pod with Scott Galloway episode “The Week: AI, GLP-1s, and Scott's Iran War Reversal”, published June 5, 2026.
In "The Week: AI, GLP-1s, and Scott's Iran War Reversal" (The Prof G Pod with Scott Galloway, June 2026), the initial optimism surrounding AI is hitting a wall as companies report exorbitant computing costs that often exceed human labor expenses. Scott Galloway argues that the market is beginning to demand tangible…
In "The Week: AI, GLP-1s, and Scott's Iran War Reversal", This concept describes the move from speculative investment to financial scrutiny. As companies analyze the compute costs versus the labor replaced, many are finding the economics do not currently make sense, leading to a scaling back of deployments.
In "The Week: AI, GLP-1s, and Scott's Iran War Reversal", Addressing a nodal condition allows for a massive reduction in secondary health risks. By effectively treating obesity with new drugs, Eli Lilly argues that they can prevent a cascade of other diseases, significantly increasing life expectancy.
In "The Week: AI, GLP-1s, and Scott's Iran War Reversal", This psychological framework encourages people to channel their stress into productive movement. Whether it is health scares or career stagnation, the act of doing something active changes one's mental state from passive victim to active participant.
The initial optimism surrounding AI is hitting a wall as companies report exorbitant computing costs that often exceed human labor expenses. Scott Galloway argues that the market is beginning to demand tangible ROI, signaling a potential shift from reckless spending to cautious procurement in the enterprise.
“Action absorbs anxiety.”
— The Prof G Pod with Scott Galloway, “The Week: AI, GLP-1s, and Scott's Iran War Reversal”
Topics: AI spending, tech bubble, corporate strategy, healthcare costs